Patient Priorities for Living Well: A Focus on Life Participation Chronic kidney disease (CKD) and its associated symptoms and treatment, including kidney replacement therapy, can disrupt daily living and impair the quality of life of patients and their family members. Consequently, this can impact treatment satisfaction and clinical outcomes. 1 To advance research, practice, and policy, there is increasing recognition of the need to identify and address patient priorities, values, and goals. 1 Several efforts have addressed these important questions, including the Standardised Outcomes in Nephrology (SONG) initiative, which includes more than 9,000 patients, family members, and health professionals from over 70 countries. 2,3 Children and adults with CKD have consistently given higher priority to symptoms and life impacts than health professionals. 2,3 In comparison, health professionals have given higher priority to mortality and hospitalization than patients and family members. The patient-prioritized outcomes are shown in Fig 1. Life participation, defined as the ability to do meaningful activities of life including, but not limited to, work, study, family responsibilities, travel, sport, social, and recreational activities, was established as a critically important outcome across all treatment stages of CKD. 1,2 Patients wanted to be able to live well, maintain their role and social functioning, protect some semblance of normality, and have a sense of control over their health and wellbeing. The quotations from patients with kidney disease provided in Box S1 demonstrate how life participation reflects the ability to live well with CKD. 4 The World Health Organization (WHO) specifically defines participation as "involvement in a life situation." 5 Life participation places the life priorities and values of those affected by CKD and their families at the center of decision making. The World Kidney Day (WKD) Steering Committee calls for the inclusion of life participation as a key focus in the care of patients with CKD to achieve the ultimate goal of living well with kidney disease. This necessitates the development and implementation of validated patientreported outcome measures that could be used to assess and address areas of life participation in routine care. Monitoring of life participation could be supported by